Ausgabe 3/2011
Inhalt (26 Artikel)
Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review
K. Dusdal, J. Grundmanis, K. Luttin, P. Ritchie, C. Rompre, R. Sidhu, S. R. Harris
Development and validation of a disease model for postmenopausal osteoporosis
A. Gauthier, J. A. Kanis, M. Martin, J. Compston, F. Borgström, C. Cooper, E. McCloskey
Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent
S. H. Kim, H. S. Choi, Y. Rhee, K. J. Kim, S.-K. Lim
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study
L.-A. Fraser, G. Ioannidis, J. D. Adachi, L. Pickard, S. M. Kaiser, J. Prior, J. P. Brown, D. A. Hanley, W. P. Olszynski, T. Anastassiades, S. Jamal, R. Josse, D. Goltzman, A. Papaioannou
Change in hip fracture incidence over the last 6 years in France
M. Maravic, P. Taupin, P. Landais, C. Roux
Proximal hip geometry and hip fracture risk assessment in a Korean population
G. I. Im, M. J. Lim
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
J. A. Kanis, H. Johansson, A. Oden, E. V. McCloskey
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment
W. D. Leslie, L. M. Lix, L. Langsetmo, C. Berger, D. Goltzman, D. A. Hanley, J. D. Adachi, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos
L.-A. Fraser, L. Langsetmo, C. Berger, G. Ioannidis, D. Goltzman, J. D. Adachi, A. Papaioannou, R. Josse, C. S. Kovacs, W. P. Olszynski, T. Towheed, D. A. Hanley, S. M. Kaiser, J. Prior, S. Jamal, N. Kreiger, J. P. Brown, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis, W. D. Leslie
Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study
A. Lih, H. Nandapalan, M. Kim, C. Yap, P. Lee, K. Ganda, M. J. Seibel
Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis
K. A. Stockton, K. Mengersen, J. D. Paratz, D. Kandiah, K. L. Bennell
Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial
I. S. Wicherts, A. J. P. Boeke, I. M. van der Meer, N. M. van Schoor, D. L. Knol, P. Lips
Maternal vitamin D status affects bone growth in early childhood—a prospective cohort study
H. T. Viljakainen, T. Korhonen, T. Hytinantti, E. K. A. Laitinen, S. Andersson, O. Mäkitie, C. Lamberg-Allardt
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
V. Rabenda, O. Bruyère, J.-Y. Reginster
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
S. Pouwels, A. Lalmohamed, P. Souverein, C. Cooper, B. J. Veldt, H. G. Leufkens, A. de Boer, T. van Staa, F. de Vries
Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta-analysis of published studies
H. Jin, E. Evangelou, J. P. A. Ioannidis, S. H. Ralston
Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism
M. Kurajoh, M. Inaba, S. Okuno, H. Nagayama, S. Yamada, Y. Imanishi, E. Ishimura, S. Shoji, T. Yamakawa, Y. Nishizawa
Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study
Graeme M. Campbell, Michael S. Ominsky, Steven K. Boyd
Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors
S. M. Cadarette, D. H. Solomon, J. N. Katz, A. R. Patrick, M. A. Brookhart
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective
F. Borgström, O. Ström, M. Kleman, E. McCloskey, H. Johansson, A. Odén, J. A. Kanis
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. A. Kanis
Oral bisphosphonates are associated with reduced mortality after hip fracture
L. A. Beaupre, D. W. Morrish, D. A. Hanley, W. P. Maksymowych, N. R. Bell, A. G. Juby, S. R. Majumdar
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene
P. Vestergaard, F. Schwartz, L. Rejnmark, L. Mosekilde
Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica
L. Moretti, A. Notarnicola, A. Panella, L. Garofalo, R. Garofalo, A. Santamato, B. Moretti